High Serum Resistin Level may be an Indicator of the Severity of Coronary Disease in Acute Coronary Syndrome

Objective To investigate the correlation between serum resistin level, cardiovascular risk factors and severity of coronary disease in acute coronary syndrome (ACS). Methods Alter evaluated by clinical history, electrocardiography, exercise tolerance tests, laboratory tests, and coronary angiography...

Full description

Saved in:
Bibliographic Details
Published inChinese medical sciences journal Vol. 24; no. 3; pp. 161 - 166
Main Authors Wang, Hao, Chen, De-you, Cao, Jian, He, Zuo-yun, Zhu, Bing-po, Long, Min
Format Journal Article
LanguageEnglish
Published China Elsevier B.V 01.09.2009
Department of Geriatric Cardiology,Chinese People's Liberation Army General Hospital,Beijing 100853,China%Out-patient Department,Chinese People's Liberation Army General Hospital,Beijing 100853,China%Department of Internal Cardiology Xinqiao Hospital,the Third Military Medical University,Chongqing 400037,China%Department of Endocrinology,Xinqiao Hospital,the Third Military Medical University,Chongqing 400037,China
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective To investigate the correlation between serum resistin level, cardiovascular risk factors and severity of coronary disease in acute coronary syndrome (ACS). Methods Alter evaluated by clinical history, electrocardiography, exercise tolerance tests, laboratory tests, and coronary angiography, 220 consecutive patients with suspected chest pain were divided into normal control group, stable angina pectoris (SAP) group, and ACS group, respectively. Baseline clinical characteristics, including height, weight, waist circumference, hip circumference, white blood cell count, high-sensitive C-reactive protein (hsCRP), total cholesterol, triglyceride, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol, were compared among three groups. ELISA was used to detect serum resistin levels. Pearson's correlation coefficient analysis was used to assess association between resistin and other traditional cardiovascular risk factors. Multinomial logistic regression analyses were used to define the relationship between serum resistin level and SAP or ACS. Results Serum resistin level in ACS group (1.18±0.48 μg/L) was significantly higher than that in normal control and SAP groups (0.49±0.40 and 0.66±0.40 μg/L; P〈0.01). Only in ACS group, increased serum resistin level was significantly correlated with hsCRP (r=0.262, P=0.004) and white blood cell count (r=0.347, P=0.001). Furthermore, serum resistin levels showed a stepwise increase with the number increase of 〉 50% stenosed coronary vessels. Multinomial logistic regression test demonstrated that serum resistin was a strong risk factor for ACS (OR=29.132, 95 % CI: 10.939-77.581, P〈0.001). Conclusion These findings suggested the potential role of resistin in atherosclerosis and especially its involvement in ACS.
AbstractList Objective To investigate the correlation between serum resistin level, cardiovascular risk factors and severity of coronary disease in acute coronary syndrome (ACS). Methods Alter evaluated by clinical history, electrocardiography, exercise tolerance tests, laboratory tests, and coronary angiography, 220 consecutive patients with suspected chest pain were divided into normal control group, stable angina pectoris (SAP) group, and ACS group, respectively. Baseline clinical characteristics, including height, weight, waist circumference, hip circumference, white blood cell count, high-sensitive C-reactive protein (hsCRP), total cholesterol, triglyceride, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol, were compared among three groups. ELISA was used to detect serum resistin levels. Pearson's correlation coefficient analysis was used to assess association between resistin and other traditional cardiovascular risk factors. Multinomial logistic regression analyses were used to define the relationship between serum resistin level and SAP or ACS. Results Serum resistin level in ACS group (1.18±0.48 μg/L) was significantly higher than that in normal control and SAP groups (0.49±0.40 and 0.66±0.40 μg/L; P〈0.01). Only in ACS group, increased serum resistin level was significantly correlated with hsCRP (r=0.262, P=0.004) and white blood cell count (r=0.347, P=0.001). Furthermore, serum resistin levels showed a stepwise increase with the number increase of 〉 50% stenosed coronary vessels. Multinomial logistic regression test demonstrated that serum resistin was a strong risk factor for ACS (OR=29.132, 95 % CI: 10.939-77.581, P〈0.001). Conclusion These findings suggested the potential role of resistin in atherosclerosis and especially its involvement in ACS.
To investigate the correlation between serum resistin level, cardiovascular risk factors and severity of coronary disease in acute coronary syndrome (ACS). After evaluated by clinical history, electrocardiography, exercise tolerance tests, laboratory tests, and coronary angiography, 220 consecutive patients with suspected chest pain were divided into normal control group, stable angina pectoris (SAP) group, and ACS group, respectively. Baseline clinical characteristics, including height, weight, waist circumference, hip circumference, white blood cell count, high-sensitive C-reactive protein (hsCRP), total cholesterol, triglyceride, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol, were compared among three groups. ELISA was used to detect serum resistin levels. Pearson's correlation coefficient analysis was used to assess association between resistin and other traditional cardiovascular risk factors. Multinomial logistic regression analyses were used to define the relationship between serum resistin level and SAP or ACS. Serum resistin level in ACS group (1.18+/-0.48 microg/L) was significantly higher than that in normal control and SAP groups (0.49+/-0.40 and 0.66+/-0.40 microg/L; P<0.01). Only in ACS group, increased serum resistin level was significantly correlated with hsCRP (r=0.262, P=0.004) and white blood cell count (r=0.347, P=0.001). Furthermore, serum resistin levels showed a stepwise increase with the number increase of > 50% stenosed coronary vessels. Multinomial logistic regression test demonstrated that serum resistin was a strong risk factor for ACS (OR=29.132, 95 % CI: 10.939-77.581, P<0.001). These findings suggested the potential role of resistin in atherosclerosis and especially its involvement in ACS.
To investigate the correlation between serum resistin level, cardiovascular risk factors and severity of coronary disease in acute coronary syndrome (ACS).OBJECTIVETo investigate the correlation between serum resistin level, cardiovascular risk factors and severity of coronary disease in acute coronary syndrome (ACS).After evaluated by clinical history, electrocardiography, exercise tolerance tests, laboratory tests, and coronary angiography, 220 consecutive patients with suspected chest pain were divided into normal control group, stable angina pectoris (SAP) group, and ACS group, respectively. Baseline clinical characteristics, including height, weight, waist circumference, hip circumference, white blood cell count, high-sensitive C-reactive protein (hsCRP), total cholesterol, triglyceride, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol, were compared among three groups. ELISA was used to detect serum resistin levels. Pearson's correlation coefficient analysis was used to assess association between resistin and other traditional cardiovascular risk factors. Multinomial logistic regression analyses were used to define the relationship between serum resistin level and SAP or ACS.METHODSAfter evaluated by clinical history, electrocardiography, exercise tolerance tests, laboratory tests, and coronary angiography, 220 consecutive patients with suspected chest pain were divided into normal control group, stable angina pectoris (SAP) group, and ACS group, respectively. Baseline clinical characteristics, including height, weight, waist circumference, hip circumference, white blood cell count, high-sensitive C-reactive protein (hsCRP), total cholesterol, triglyceride, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol, were compared among three groups. ELISA was used to detect serum resistin levels. Pearson's correlation coefficient analysis was used to assess association between resistin and other traditional cardiovascular risk factors. Multinomial logistic regression analyses were used to define the relationship between serum resistin level and SAP or ACS.Serum resistin level in ACS group (1.18+/-0.48 microg/L) was significantly higher than that in normal control and SAP groups (0.49+/-0.40 and 0.66+/-0.40 microg/L; P<0.01). Only in ACS group, increased serum resistin level was significantly correlated with hsCRP (r=0.262, P=0.004) and white blood cell count (r=0.347, P=0.001). Furthermore, serum resistin levels showed a stepwise increase with the number increase of > 50% stenosed coronary vessels. Multinomial logistic regression test demonstrated that serum resistin was a strong risk factor for ACS (OR=29.132, 95 % CI: 10.939-77.581, P<0.001).RESULTSSerum resistin level in ACS group (1.18+/-0.48 microg/L) was significantly higher than that in normal control and SAP groups (0.49+/-0.40 and 0.66+/-0.40 microg/L; P<0.01). Only in ACS group, increased serum resistin level was significantly correlated with hsCRP (r=0.262, P=0.004) and white blood cell count (r=0.347, P=0.001). Furthermore, serum resistin levels showed a stepwise increase with the number increase of > 50% stenosed coronary vessels. Multinomial logistic regression test demonstrated that serum resistin was a strong risk factor for ACS (OR=29.132, 95 % CI: 10.939-77.581, P<0.001).These findings suggested the potential role of resistin in atherosclerosis and especially its involvement in ACS.CONCLUSIONThese findings suggested the potential role of resistin in atherosclerosis and especially its involvement in ACS.
R3; Objective To investigate the correlation between serum resistin level,cardiovascular risk factors and severity of coronary disease in acute coronary syndrome(ACS).Methods After evaluated by clinical history,electrocardiography,exercise tolerance tests,laboratory tests,and coronary angiography,220 consecutive patients with suspected chest pain were divided into normal control group,stable angina pectoris(SAP)group,and ACS group,respectively.Baseline clinical characteristics,including height,weight,waist circumference,hip circumference,white blood cell count,high-sensitive C-reactive protein(hsCRP),total cholesterol,triglyceride,low-density lipoprotein cholesterol and high-density lipoprotein cholesterol,were compared among three groups.ELISA was used to detect serum resistin levels.Pearson's correlation coefficient analysis was used to assess association between resistin nd other traditional cardiovascular risk factors.Multinomial logistic regression analyses were used to define the relationship between serum resistin level and SAP or ACS.Results Serum resistin level in ACS group(1.18±0.48 μg/L)was significantly higher than that in normal control and SAP groups(0.49±0.40 and 0.66±0.40 μg/L;P<0.01).Only in ACS group,increased serum resistin level was significantly correlated with hsCRP(r=0.262,P=0.004)and white blood cell count (r=0.347,P=0.001).Furthermore,serum resistin levels showed a stepwise increase with the number in crease of > 50% stenosed coronary vessels.Multinomial logistic regression test demonstrated that serum resistin was a strong risk factor for ACS(OR=29.132,95 % CI:10.93% 77.581,P<0.001).Conclusion These findings suggested the potential role of resistin in atherosclerosis and especially its involvement in ACS.
To investigate the correlation between serum resistin level, cardiovascular risk factors and severity of coronary disease in acute coronary syndrome (ACS). After evaluated by clinical history, electrocardiography, exercise tolerance tests, laboratory tests, and coronary angiography, 220 consecutive patients with suspected chest pain were divided into normal control group, stable angina pectoris (SAP) group, and ACS group, respectively. Baseline clinical characteristics, including height, weight, waist circumference, hip circumference, white blood cell count, high-sensitive C-reactive protein (hsCRP), total cholesterol, triglyceride, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol, were compared among three groups. ELISA was used to detect serum resistin levels. Pearson's correlation coefficient analysis was used to assess association between resistin and other traditional cardiovascular risk factors. Multinomial logistic regression analyses were used to define the relationship between serum resistin level and SAP or ACS. Serum resistin level in ACS group (1.18±0.48 μg/L) was significantly higher than that in normal control and SAP groups (0.49±0.40 and 0.66±0.40 μg/L; P<0.01). Only in ACS group, increased serum resistin level was significantly correlated with hsCRP ( r=0.262, P=0.004) and white blood cell count ( r=0.347, P=0.001). Furthermore, serum resistin levels showed a stepwise increase with the number increase of > 50% stenosed coronary vessels. Multinomial logistic regression test demonstrated that serum resistin was a strong risk factor for ACS ( OR=29.132, 95% CI: 10.939–77.581, P<0.001). These findings suggested the potential role of resistin in atherosclerosis and especially its involvement in ACS.
Author Hao Wang De-you Chen Jian Cao Zuo-yun He Bing-po Zhu Min Long
AuthorAffiliation Department of Geriatric Cardiology Out-patient Department, Chinese People's Liberation Army General Hospital, Beijing 100853, China Department of Internal Cardiology Department of Endocrinology, Xinqiao Hospital, the Third Military Medical University, Chongqing 400037, China
AuthorAffiliation_xml – name: Department of Geriatric Cardiology,Chinese People's Liberation Army General Hospital,Beijing 100853,China%Out-patient Department,Chinese People's Liberation Army General Hospital,Beijing 100853,China%Department of Internal Cardiology Xinqiao Hospital,the Third Military Medical University,Chongqing 400037,China%Department of Endocrinology,Xinqiao Hospital,the Third Military Medical University,Chongqing 400037,China
Author_xml – sequence: 1
  givenname: Hao
  surname: Wang
  fullname: Wang, Hao
  organization: Department of Geriatric Cardiology, Chinese People's Liberation Army General Hospital, Beijing 100853, China
– sequence: 2
  givenname: De-you
  surname: Chen
  fullname: Chen, De-you
  email: calvin301@163.com
  organization: Out-patient Department, Chinese People's Liberation Army General Hospital, Beijing 100853, China
– sequence: 3
  givenname: Jian
  surname: Cao
  fullname: Cao, Jian
  organization: Department of Geriatric Cardiology, Chinese People's Liberation Army General Hospital, Beijing 100853, China
– sequence: 4
  givenname: Zuo-yun
  surname: He
  fullname: He, Zuo-yun
  organization: Department of Internal Cardiology, the Third Military Medical University, Chongqing 400037, China
– sequence: 5
  givenname: Bing-po
  surname: Zhu
  fullname: Zhu, Bing-po
  organization: Department of Geriatric Cardiology, Chinese People's Liberation Army General Hospital, Beijing 100853, China
– sequence: 6
  givenname: Min
  surname: Long
  fullname: Long, Min
  organization: Department of Endocrinology, Xinqiao Hospital, the Third Military Medical University, Chongqing 400037, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19848317$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtvEzEUhb0oog_4CSCLDbAYuI5n7LFYVFV4tFIkJAJry-O5kzjM2K09E5R_j9OEVmJTbyzb3zlXPuecnPjgkZBXDD4wYOLjkgGwQs1U-Q7UewFQzwp2Qs4erk_JeUobABCsLp-TU6bqsuZMnpH-2q3WdIlxGugPTC6NztMFbrGng9nRBqnx9Ma3zpoxRBo6Oq4x81uMbtztz_MQgzdxRz-7hCYhzQZXdhrx8WW5820MA74gzzrTJ3x53C_Ir69ffs6vi8X3bzfzq0VhOa9FIUCiyquroGPIrVCiqVTdCNbIiou25A1gjcLMTF1XKIGLsrK8lFUjRVlyfkHeHnz_GN8Zv9KbMEWfJ2o7pI3GGYACntN4JG9juJswjXpwyWLfG49hSlryEpSs1J58fSSnZsBW30Y35L_pf1Fm4NMBsDGkFLHT1o1mdMGP0bheM9D7svR9WXrfigal78vSLKur_9QPA57QXR50mPPcOow6WYfeYusi2lG3wT3p8OY4eR386s7luBpjf3euR81nIKQSkv8FHai2gw
CitedBy_id crossref_primary_10_1007_s11010_014_1993_7
crossref_primary_10_5551_jat_19273
crossref_primary_10_1089_jmf_2013_2916
crossref_primary_10_1016_j_tranon_2021_101178
crossref_primary_10_1155_2012_125458
crossref_primary_10_1016_j_biopha_2018_09_160
crossref_primary_10_3760_cma_j_issn_0366_6999_20123548
crossref_primary_10_1111_jne_12495
crossref_primary_10_1016_j_atherosclerosis_2016_08_015
crossref_primary_10_3390_nu8090460
crossref_primary_10_3390_life14010093
crossref_primary_10_18632_oncotarget_15707
crossref_primary_10_1016_j_jnutbio_2015_02_001
crossref_primary_10_3390_ijms23169338
crossref_primary_10_3899_jrheum_110237
crossref_primary_10_3390_biom10030374
crossref_primary_10_1007_s11883_017_0644_3
crossref_primary_10_3389_fpubh_2024_1484195
crossref_primary_10_1016_j_ejr_2018_11_005
crossref_primary_10_1016_j_tem_2011_03_005
crossref_primary_10_1111_jvim_14570
crossref_primary_10_1111_j_1476_5381_2011_01369_x
crossref_primary_10_3390_ijerph182312746
crossref_primary_10_52547_ismj_23_3_222
crossref_primary_10_5494_wjh_v2_i1_13
crossref_primary_10_3390_nu9111271
crossref_primary_10_4093_dmj_2013_37_6_404
crossref_primary_10_1152_ajpheart_00431_2009
crossref_primary_10_1016_j_domaniend_2020_106506
crossref_primary_10_14341_omet201745_9
crossref_primary_10_1139_y2012_053
crossref_primary_10_1177_0003319713520463
crossref_primary_10_1016_j_tcm_2012_01_004
crossref_primary_10_1161_CIRCRESAHA_115_306885
Cites_doi 10.1254/jphs.FP0072173
10.1016/j.atherosclerosis.2005.02.014
10.1210/en.2004-0985
10.1016/j.cardiores.2005.09.015
10.1016/j.jacc.2005.04.022
10.1016/j.metabol.2008.01.005
10.1007/s00125-006-0187-6
10.1016/j.atherosclerosis.2006.05.039
10.1016/S0735-1097(01)01485-1
10.1210/jc.2005-0742
10.1111/j.1365-2265.2005.02207.x
10.1016/j.cardiores.2006.01.015
10.1016/j.bbrc.2003.12.104
10.1038/35053000
10.1210/jc.2005-1653
10.1371/journal.pmed.0010045
10.2337/db05-0615
10.1053/euhj.2001.2889
10.1253/circj.72.1249
10.1016/j.nutres.2004.07.002
10.1016/j.bbrc.2003.07.003
10.1161/01.CIR.0000155620.10387.43
ClassificationCodes R3
ContentType Journal Article
Copyright 2009 Chinese Academy Medical Sciences
Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: 2009 Chinese Academy Medical Sciences
– notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W94
WU4
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.1016/S1001-9294(09)60082-1
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-自然科学
中文科技期刊数据库-自然科学-生物科学
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate High Serum Resistin Level may be an Indicator of the Severity of Coronary Disease in Acute Coronary Syndrome
EndPage 166
ExternalDocumentID cmsj_e200903006
19848317
10_1016_S1001_9294_09_60082_1
S1001929409600821
32067967
Genre Journal Article
GroupedDBID ---
--K
-05
-0E
-SE
-S~
.~1
0R~
1B1
1~.
1~5
29B
2B.
2C~
2RA
4.4
457
4G.
53G
5GY
5VR
5VS
5XA
5XF
5XL
7-5
71M
92F
92I
92L
92M
93N
93R
9D9
9DE
AAEDT
AALRI
AAQFI
AAXUO
ABBQC
ABKZE
ABPTK
AEKER
AFTJW
AFUIB
AGYEJ
AITUG
AJRQY
ALMA_UNASSIGNED_HOLDINGS
CAJEE
CAJUS
CCEZO
CDYEO
CHBEP
CIEJG
CQIGP
CW9
CXBCV
DU5
EBS
EJD
EP2
EP3
FA0
FDB
FNPLU
GBLVA
HZ~
IPNFZ
J1W
JUIAU
M41
MO0
N9A
O-L
O9-
OZT
P-8
P-9
PC.
Q--
Q-4
Q38
R-E
RIG
ROL
RT5
S..
SDF
SES
T8U
TCJ
TGQ
U1F
U1G
U5E
U5O
W94
WFFXF
WU4
~WA
ADMUD
AAYXX
ABWVN
ACRPL
ADNMO
AIGII
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
4A8
PSX
ID FETCH-LOGICAL-c3386-607e9999f50f1e3c696b598b61b7536d43b0e8e6a2a885e703645c3475b764433
IEDL.DBID .~1
ISSN 1001-9294
IngestDate Thu May 29 04:10:08 EDT 2025
Fri Jul 11 12:03:18 EDT 2025
Mon Jul 21 05:54:49 EDT 2025
Tue Jul 01 01:55:45 EDT 2025
Thu Apr 24 23:03:25 EDT 2025
Fri Feb 23 02:29:43 EST 2024
Fri Nov 25 19:12:45 EST 2022
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords atherosclerosis
resistin
acute coronary syndrome
stable angina pectoris
Language English
License http://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3386-607e9999f50f1e3c696b598b61b7536d43b0e8e6a2a885e703645c3475b764433
Notes atherosclerosis
acute coronary syndrome
resistin
X823
Q51
resistin; atherosclerosis; acute coronary syndrome; stable angina pectoris
stable angina pectoris
11-2752/R
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 19848317
PQID 734097596
PQPubID 23479
PageCount 6
ParticipantIDs wanfang_journals_cmsj_e200903006
proquest_miscellaneous_734097596
pubmed_primary_19848317
crossref_citationtrail_10_1016_S1001_9294_09_60082_1
crossref_primary_10_1016_S1001_9294_09_60082_1
elsevier_sciencedirect_doi_10_1016_S1001_9294_09_60082_1
chongqing_backfile_32067967
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-Sep
PublicationDateYYYYMMDD 2009-09-01
PublicationDate_xml – month: 09
  year: 2009
  text: 2009-Sep
PublicationDecade 2000
PublicationPlace China
PublicationPlace_xml – name: China
PublicationTitle Chinese medical sciences journal
PublicationTitleAlternate Chinese Medical Sciences Journal
PublicationTitle_FL CHINESE MEDICAL SCIENCES JOURNAL
PublicationYear 2009
Publisher Elsevier B.V
Department of Geriatric Cardiology,Chinese People's Liberation Army General Hospital,Beijing 100853,China%Out-patient Department,Chinese People's Liberation Army General Hospital,Beijing 100853,China%Department of Internal Cardiology Xinqiao Hospital,the Third Military Medical University,Chongqing 400037,China%Department of Endocrinology,Xinqiao Hospital,the Third Military Medical University,Chongqing 400037,China
Publisher_xml – name: Elsevier B.V
– name: Department of Geriatric Cardiology,Chinese People's Liberation Army General Hospital,Beijing 100853,China%Out-patient Department,Chinese People's Liberation Army General Hospital,Beijing 100853,China%Department of Internal Cardiology Xinqiao Hospital,the Third Military Medical University,Chongqing 400037,China%Department of Endocrinology,Xinqiao Hospital,the Third Military Medical University,Chongqing 400037,China
References Lubos, Messow, Schnabel (bib16) 2007; 193
Lakkaa, Lakkaa, Tuomilehtod (bib12) 2002; 23
Furman, Barnard, Krueger (bib22) 2001; 39
Fruhbeck, Salvador (bib5) 2004; 4
Ohmori, Momiyama, Kato (bib15) 2005; 46
Diez, Iglesias, Fernandez-Reyes (bib18) 2005; 62
Burnett, Devaney, Adenika (bib19) 2006; 91
Rae, Graham (bib24) 2006; 49
Sato, Kobayashi, Inoguchi (bib13) 2005; 146
Chu, Ding, Li (bib17) 2008; 72
Qi, Nie, Lee (bib2) 2006; 55
Isomaa, Almgren, Tuomi (bib11) 2001; 289
Jung, Park, Cho (bib9) 2006; 69
Reilly, Lehrke, Wolfe (bib14) 2005; 111
Lehrke, Reilly, Millington (bib21) 2004; 1
Barb, Wadhwa, Kratzsch (bib20) 2005; 90
Tomimoto, Ojika, Shintani (bib3) 2008; 107
Rubin, McMurray, Harrell (bib4) 2008; 57
Steppan, Bailey, Bhat (bib1) 2001; 409
NHLBI Obesity Education Initiative (bib10) 1998
Kawanamia, Maemura, Takedaa (bib7) 2004; 314
Burnett, Leea, Kinnairda (bib8) 2005; 18
Mu, Ohashi, Yan (bib23) 2006; 70
Kasera, Kaserb, Sandhofera (bib6) 2003; 309
Isomaa (10.1016/S1001-9294(09)60082-1_bib11) 2001; 289
Jung (10.1016/S1001-9294(09)60082-1_bib9) 2006; 69
Furman (10.1016/S1001-9294(09)60082-1_bib22) 2001; 39
Tomimoto (10.1016/S1001-9294(09)60082-1_bib3) 2008; 107
Barb (10.1016/S1001-9294(09)60082-1_bib20) 2005; 90
Lehrke (10.1016/S1001-9294(09)60082-1_bib21) 2004; 1
Diez (10.1016/S1001-9294(09)60082-1_bib18) 2005; 62
Burnett (10.1016/S1001-9294(09)60082-1_bib19) 2006; 91
Lubos (10.1016/S1001-9294(09)60082-1_bib16) 2007; 193
Qi (10.1016/S1001-9294(09)60082-1_bib2) 2006; 55
Fruhbeck (10.1016/S1001-9294(09)60082-1_bib5) 2004; 4
Kawanamia (10.1016/S1001-9294(09)60082-1_bib7) 2004; 314
Rae (10.1016/S1001-9294(09)60082-1_bib24) 2006; 49
Chu (10.1016/S1001-9294(09)60082-1_bib17) 2008; 72
Kasera (10.1016/S1001-9294(09)60082-1_bib6) 2003; 309
Rubin (10.1016/S1001-9294(09)60082-1_bib4) 2008; 57
Steppan (10.1016/S1001-9294(09)60082-1_bib1) 2001; 409
NHLBI Obesity Education Initiative (10.1016/S1001-9294(09)60082-1_bib10) 1998
Mu (10.1016/S1001-9294(09)60082-1_bib23) 2006; 70
Sato (10.1016/S1001-9294(09)60082-1_bib13) 2005; 146
Lakkaa (10.1016/S1001-9294(09)60082-1_bib12) 2002; 23
Ohmori (10.1016/S1001-9294(09)60082-1_bib15) 2005; 46
Reilly (10.1016/S1001-9294(09)60082-1_bib14) 2005; 111
Burnett (10.1016/S1001-9294(09)60082-1_bib8) 2005; 18
References_xml – volume: 193
  start-page: 121
  year: 2007
  end-page: 128
  ident: bib16
  article-title: Resistin, acute coronary syndrome and prognosis results from the AtheroGene study
  publication-title: Atherosclerosis
– volume: 4
  start-page: 803
  year: 2004
  end-page: 826
  ident: bib5
  article-title: Role of adipocytokines in metabolism and disease
  publication-title: Nutrition Research
– volume: 69
  start-page: 76
  year: 2006
  end-page: 85
  ident: bib9
  article-title: Resistin is secreted from macrophages in atheromas and promotes atherosclerosis
  publication-title: Cardiovasc Res
– volume: 70
  start-page: 146
  year: 2006
  end-page: 157
  ident: bib23
  article-title: Adipokine resistin promotes
  publication-title: Cardiovasc Res
– volume: 62
  start-page: 242
  year: 2005
  end-page: 249
  ident: bib18
  article-title: Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease
  publication-title: Clin Endocrinol (Oxf)
– volume: 49
  start-page: 1112
  year: 2006
  end-page: 1114
  ident: bib24
  article-title: Human resistin promotes macrophage lipid accumulation
  publication-title: Diabetologia
– volume: 57
  start-page: 683
  year: 2008
  end-page: 690
  ident: bib4
  article-title: The association between insulin resistance and cytokines in adolescents: the role of weight status and exercise
  publication-title: Metabolism
– volume: 23
  start-page: 706
  year: 2002
  end-page: 713
  ident: bib12
  article-title: Abdominal obesity is associated with increased risk of acute coronary events in men
  publication-title: Eur Heart J
– volume: 289
  start-page: 76
  year: 2001
  end-page: 79
  ident: bib11
  article-title: Cardiovascular morbidity and mortality associated with the metabolic syndrome
  publication-title: Diabetes Care
– volume: 46
  start-page: 379
  year: 2005
  end-page: 380
  ident: bib15
  article-title: Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease
  publication-title: J Am Coll Cardiol
– volume: 91
  start-page: 64
  year: 2006
  end-page: 68
  ident: bib19
  article-title: Cross-sectional associations of resistin, coronary heart disease, and insulin resistance
  publication-title: J Clin Endocrinol Metab
– year: 1998
  ident: bib10
  publication-title: Clinical Guideline on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults: the Evidence Report
– volume: 72
  start-page: 1449
  year: 2008
  end-page: 2253
  ident: bib17
  article-title: Plasma resistin associated with myocardium injury in patients with acute coroanry syndrome
  publication-title: Cir J
– volume: 1
  start-page: 161
  year: 2004
  end-page: 168
  ident: bib21
  article-title: An inflammatory cascade leading to hyperresistinemia in humans
  publication-title: PLoS Med
– volume: 409
  start-page: 307
  year: 2001
  end-page: 312
  ident: bib1
  article-title: The hormone resistin links obesity to diabetes
  publication-title: Nature
– volume: 314
  start-page: 415
  year: 2004
  end-page: 419
  ident: bib7
  article-title: Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions
  publication-title: Biochem Biophys Res Commun
– volume: 18
  start-page: 241
  year: 2005
  end-page: 248
  ident: bib8
  article-title: The potential role of resistin in atherosclerosis
  publication-title: Atherosclerosis
– volume: 309
  start-page: 286
  year: 2003
  end-page: 290
  ident: bib6
  article-title: Resistin messenger-RNA expression is increased by proinflammatory cytokines
  publication-title: Biochem Biophys Res Commun
– volume: 146
  start-page: 2
  year: 2005
  ident: bib13
  article-title: Adenovirus-mediated high expression of resistin causes dyslipidemia in mice
  publication-title: Endocrinology
– volume: 90
  start-page: 5324
  year: 2005
  end-page: 5328
  ident: bib20
  article-title: Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with the highly active antiretroviral therapy-induced metabolic syndrome
  publication-title: J Clin Endocrinol Metab
– volume: 107
  start-page: 41
  year: 2008
  end-page: 48
  ident: bib3
  article-title: Markedly reduced white adipose tissue and increased insulin sensitivity in adcyap1-deficient mice
  publication-title: J Pharmacol Sci
– volume: 39
  start-page: 1002
  year: 2001
  end-page: 1006
  ident: bib22
  article-title: Circulating monocyte–platelet aggregates are an early marker of acute myocardial injury
  publication-title: J Am Coll Cardiol
– volume: 111
  start-page: 932
  year: 2005
  end-page: 939
  ident: bib14
  article-title: Resistin is an inflammatory marker of atherosclerosis in humans
  publication-title: Circulation
– volume: 55
  start-page: 3083
  year: 2006
  end-page: 3090
  ident: bib2
  article-title: Loss of resistin improves glucose homeostasis in leptin deficiency
  publication-title: Diabetes
– volume: 107
  start-page: 41
  year: 2008
  ident: 10.1016/S1001-9294(09)60082-1_bib3
  article-title: Markedly reduced white adipose tissue and increased insulin sensitivity in adcyap1-deficient mice
  publication-title: J Pharmacol Sci
  doi: 10.1254/jphs.FP0072173
– volume: 18
  start-page: 241
  year: 2005
  ident: 10.1016/S1001-9294(09)60082-1_bib8
  article-title: The potential role of resistin in atherosclerosis
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2005.02.014
– volume: 146
  start-page: 2
  year: 2005
  ident: 10.1016/S1001-9294(09)60082-1_bib13
  article-title: Adenovirus-mediated high expression of resistin causes dyslipidemia in mice
  publication-title: Endocrinology
  doi: 10.1210/en.2004-0985
– volume: 69
  start-page: 76
  year: 2006
  ident: 10.1016/S1001-9294(09)60082-1_bib9
  article-title: Resistin is secreted from macrophages in atheromas and promotes atherosclerosis
  publication-title: Cardiovasc Res
  doi: 10.1016/j.cardiores.2005.09.015
– year: 1998
  ident: 10.1016/S1001-9294(09)60082-1_bib10
– volume: 46
  start-page: 379
  year: 2005
  ident: 10.1016/S1001-9294(09)60082-1_bib15
  article-title: Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2005.04.022
– volume: 57
  start-page: 683
  year: 2008
  ident: 10.1016/S1001-9294(09)60082-1_bib4
  article-title: The association between insulin resistance and cytokines in adolescents: the role of weight status and exercise
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2008.01.005
– volume: 49
  start-page: 1112
  year: 2006
  ident: 10.1016/S1001-9294(09)60082-1_bib24
  article-title: Human resistin promotes macrophage lipid accumulation
  publication-title: Diabetologia
  doi: 10.1007/s00125-006-0187-6
– volume: 193
  start-page: 121
  year: 2007
  ident: 10.1016/S1001-9294(09)60082-1_bib16
  article-title: Resistin, acute coronary syndrome and prognosis results from the AtheroGene study
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2006.05.039
– volume: 39
  start-page: 1002
  year: 2001
  ident: 10.1016/S1001-9294(09)60082-1_bib22
  article-title: Circulating monocyte–platelet aggregates are an early marker of acute myocardial injury
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(01)01485-1
– volume: 90
  start-page: 5324
  year: 2005
  ident: 10.1016/S1001-9294(09)60082-1_bib20
  article-title: Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with the highly active antiretroviral therapy-induced metabolic syndrome
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-0742
– volume: 62
  start-page: 242
  year: 2005
  ident: 10.1016/S1001-9294(09)60082-1_bib18
  article-title: Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2005.02207.x
– volume: 70
  start-page: 146
  year: 2006
  ident: 10.1016/S1001-9294(09)60082-1_bib23
  article-title: Adipokine resistin promotes in vitro angiogenesis of human endothelial cells
  publication-title: Cardiovasc Res
  doi: 10.1016/j.cardiores.2006.01.015
– volume: 314
  start-page: 415
  year: 2004
  ident: 10.1016/S1001-9294(09)60082-1_bib7
  article-title: Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2003.12.104
– volume: 409
  start-page: 307
  year: 2001
  ident: 10.1016/S1001-9294(09)60082-1_bib1
  article-title: The hormone resistin links obesity to diabetes
  publication-title: Nature
  doi: 10.1038/35053000
– volume: 91
  start-page: 64
  year: 2006
  ident: 10.1016/S1001-9294(09)60082-1_bib19
  article-title: Cross-sectional associations of resistin, coronary heart disease, and insulin resistance
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-1653
– volume: 1
  start-page: 161
  year: 2004
  ident: 10.1016/S1001-9294(09)60082-1_bib21
  article-title: An inflammatory cascade leading to hyperresistinemia in humans
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.0010045
– volume: 55
  start-page: 3083
  year: 2006
  ident: 10.1016/S1001-9294(09)60082-1_bib2
  article-title: Loss of resistin improves glucose homeostasis in leptin deficiency
  publication-title: Diabetes
  doi: 10.2337/db05-0615
– volume: 23
  start-page: 706
  year: 2002
  ident: 10.1016/S1001-9294(09)60082-1_bib12
  article-title: Abdominal obesity is associated with increased risk of acute coronary events in men
  publication-title: Eur Heart J
  doi: 10.1053/euhj.2001.2889
– volume: 72
  start-page: 1449
  year: 2008
  ident: 10.1016/S1001-9294(09)60082-1_bib17
  article-title: Plasma resistin associated with myocardium injury in patients with acute coroanry syndrome
  publication-title: Cir J
  doi: 10.1253/circj.72.1249
– volume: 4
  start-page: 803
  year: 2004
  ident: 10.1016/S1001-9294(09)60082-1_bib5
  article-title: Role of adipocytokines in metabolism and disease
  publication-title: Nutrition Research
  doi: 10.1016/j.nutres.2004.07.002
– volume: 309
  start-page: 286
  year: 2003
  ident: 10.1016/S1001-9294(09)60082-1_bib6
  article-title: Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2003.07.003
– volume: 289
  start-page: 76
  year: 2001
  ident: 10.1016/S1001-9294(09)60082-1_bib11
  article-title: Cardiovascular morbidity and mortality associated with the metabolic syndrome
  publication-title: Diabetes Care
– volume: 111
  start-page: 932
  year: 2005
  ident: 10.1016/S1001-9294(09)60082-1_bib14
  article-title: Resistin is an inflammatory marker of atherosclerosis in humans
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000155620.10387.43
SSID ssj0006184
Score 2.0190358
Snippet Objective To investigate the correlation between serum resistin level, cardiovascular risk factors and severity of coronary disease in acute coronary syndrome...
To investigate the correlation between serum resistin level, cardiovascular risk factors and severity of coronary disease in acute coronary syndrome (ACS)....
To investigate the correlation between serum resistin level, cardiovascular risk factors and severity of coronary disease in acute coronary syndrome...
R3; Objective To investigate the correlation between serum resistin level,cardiovascular risk factors and severity of coronary disease in acute coronary...
SourceID wanfang
proquest
pubmed
crossref
elsevier
chongqing
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 161
SubjectTerms acute coronary syndrome
Acute Coronary Syndrome - blood
Acute Coronary Syndrome - pathology
Acute Coronary Syndrome - physiopathology
Aged
atherosclerosis
Biomarkers - blood
Case-Control Studies
Coronary Disease - blood
Coronary Disease - pathology
Coronary Disease - physiopathology
Female
Humans
Male
Middle Aged
resistin
Resistin - blood
Risk Factors
stable angina pectoris
严重程度
冠心病
急性冠状动脉综合征
抵抗素
Title High Serum Resistin Level may be an Indicator of the Severity of Coronary Disease in Acute Coronary Syndrome
URI http://lib.cqvip.com/qk/86798X/20093/32067967.html
https://dx.doi.org/10.1016/S1001-9294(09)60082-1
https://www.ncbi.nlm.nih.gov/pubmed/19848317
https://www.proquest.com/docview/734097596
https://d.wanfangdata.com.cn/periodical/cmsj-e200903006
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhkNJLSbevbZqiQwktxFnbelg-hm1DWpoSmgRyE5JXTtNmtUm8e_Alvz0zsnbdUkqgF4NtSQjPaOaTv5kRIe8mxuS5YyZBUibhFjasRuWTpMgyZmouXK0wd_jomzw841_OxfkaGS9zYTCsMtr-zqYHax2fjOLXHF1fXo5OsgBPSo4gHBxZyGDnBWr53l0f5oEHmgTGE2aBrfssnm6E8PB9Wn4IgyQZ1lj4MfMXN-A5_uWr_saiIeXH18Zf_OadDjbJkwgr6X4386dkzfkB2egOmmwH5NFRpNAHZOe4K1bd7tLTPveq2aU79LgvY90-I1cYAkLBliym9Ltr0BZ4-hVjjOjUtNQ6ajz97JHngX07ndUUsCS0h7UByB7vx1gdwdy29GPHAlEYYL9azF3_5iQWTHhOzg4-nY4Pk3g2Q1LBplYmMi0cYMuyFmmdOVbJUlpRKiszCxsgOeHMpk45aXKjlHBFoDsrxgthC4BgjL0g637m3StCa15yo1LjAGzwDK524gQrclELm1fWDsnWSiLg26tfWLFKszz8AiuGhC9lpKtY1hxP17jSq_g1FLNGMeu01EHMOhuSvVW3666ux0Md1FIB9B8KqsH3PNSVLhVGw-JFRsZ4N1s0umBYbkyUckhedorUT6ZUXAG4g85Rs3S0Lo2ups1P7ZDXAhOdytf_P7Ut8rijxzBo7g1Zn98u3DagrLl9G5bRPZ72GvE
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLemIWAXBAVGGR8-oAmkZU3ijzjHqTB10E4T66TdLDt1xsbqjrU95MLfzntO2oAQmsQlUhLbsvK-fi_vw4S8mxiTpo6ZCIMyEbfgsBqVTqIsSZgpuXClwtrh0bEcnPHP5-J8g_RXtTCYVtno_lqnB23dPOk1X7N3c3nZO00CPMk5gnAwZOAC3eMgviid-z_bPA880SSEPGEbOLwt46mXCA_fx_mHsEqUYJOFbzN_8QNMx7-M1d9gNNT8-NL4i9_M0-Fj8qjBlfSg3voTsuF8h9yvT5qsOuTBqImhd8juSd2tutqj47b4ar5Hd-lJ28e6ekquMQeEgjJZTulXN0dl4OkQk4zo1FTUOmo8PfIY6AHHnc5KCmASxoNwALTH-z62RzC3Ff1Yh4EoLHBQLBeufXPadEx4Rs4OP437g6g5nCEqwKuVkYwzB-AyL0VcJo4VMpdW5MrKxIIHJCec2dgpJ01qlBIuC_HOgvFM2AwwGGPPyaafefeC0JLn3KjYOEAbPIGrnTjBslSUwqaFtV2ys6YIGPfiO7as0iwN_8CyLuErGumi6WuOx2tc63UCG5JZI5l1nOtAZp10yf562k3d2OOuCWrFAPoPDtVgfO6aSlcMo0F6MSRjvJst5zpj2G9M5LJLtmtGajeTK64A3cHkhrN0o17mupjOr7TDwBbo6Fi-_P-tvSUPB-PRUA-Pjr_skK06VoYZdK_I5uJ26V4D5FrYN0GkfgHLPh4M
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+Serum+Resistin+Level+may+be+an+Indicator+of+the+Severity+of+Coronary+Disease+in+Acute+Coronary+Syndrome&rft.jtitle=Chinese+medical+sciences+journal&rft.au=Hao+Wang+De-you+Chen+Jian+Cao+Zuo-yun+He+Bing-po+Zhu+Min+Long&rft.date=2009-09-01&rft.issn=1001-9294&rft.volume=24&rft.issue=3&rft.spage=161&rft.epage=166&rft_id=info:doi/10.1016%2FS1001-9294%2809%2960082-1&rft.externalDocID=32067967
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F86798X%2F86798X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fcmsj-e%2Fcmsj-e.jpg